Viewing StudyNCT00010049



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00010049
Status: COMPLETED
Last Update Posted: 2018-06-27
First Post: 2001-02-02

Brief Title: Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions & Keywords Data

Conditions:
Name
Brain and Central Nervous System Tumors
Keywords:
Name View
adult gliosarcoma View
recurrent adult brain tumor View
adult meningioma View
adult glioblastoma View
adult anaplastic astrocytoma View
adult anaplastic oligodendroglioma View
adult mixed glioma View
adult pilocytic astrocytoma View
adult subependymoma View
adult grade III meningioma View
adult giant cell glioblastoma View